We are monitoring the impact of COVID-19 & Recession alarm on Europe BBB Technologies Market Get in touch with us for detailed analysis Know More

Know More

Share on

Europe Blood Brain Barrier Technologies Market Research Report - By Region - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 4433
Pages: 145

Europe Blood-Brain Barrier Technologies Market Size & Growth (2022 to 2027):

The European Blood-Brain Barrier Technologies Market Size was valued at USD 166.08 Million in 2022 and is expected to reach USD 431.90 Million by 2027, to grow at a promising CAGR of 21.06% during the forecast period 2022 to 2027.

Increasing incidence of neurological diseases such as meningitis, multiple sclerosis, Parkinson's disease, and encephalitis, rising geriatric population, rising healthcare spending, rising investment in research and development for the development of new drugs & delivery devices, increasing awareness about healthcare & number of initiatives by various governments and government associations are some of the key factors driving healthcare in Europe.

The blood-brain barrier protects neuronal tissue from hazardous substances and provides a stable environment. Unfortunately, because this barrier is so good at preventing foreign substances from passing through, it frequently enhances the penetration of life-saving medications to treat injuries and diseases.

Another essential issue is the development of new delivery methods for medications and bio-macromolecules to the central nervous system (CNS), which is critical for treating neurodegenerative illnesses.

The vast pool of patients, increased awareness of the condition, better healthcare infrastructure, and rising government financing drive the blood-brain barrier technology market in developing nations.

Drugs and delivery devices that can cross the blood-brain barrier are being developed, which will help the Europe blood-brain barrier technologies market grow. Teva Pharmaceuticals Industries is a crucial player in the Europe blood-brain barrier technology market.

The fundamental role of these blood-brain barriers is to protect brain health by preventing pathogens from entering the brain, including the most prevalent infectious bacteria and viruses and other pathogens.

However, in most countries, complex regulatory frameworks for medication approval and long approval times for pharmaceuticals due to the lack of knowledge of the brain are significant limitations to the Europe blood-brain barrier technology market's growth.

Geographically, the Europe region holds the second-largest share in the global market regarding revenue and blood-brain barrier technology, owing to the increased prevalence of neurological disorders and the region's growing elderly population.

The U.K Blood-Brain Barrier Technologies Market has the greatest revenue stake and is expected to have a significant growth rate.

The blood-brain barrier is distinguished by a semipermeable dynamic interface that divides the capillaries that supply blood to the brain & the spinal cord tissue by preventing some chemicals from passing through.

In research and development, the blood-brain barrier vessels are specialized endothelial cells that line brain capillaries from the vascular system and allow for rapid molecular exchange between veins and tissues.

Blood-brain barriers cause CNS medication delivery concerns, prompting manufacturers to increase their efforts in R&D to develop novel pharmaceuticals and drug delivery systems that address CNS drug delivery issues and also can open new doors for the blood brain technologies market in terms of future possibilities since many brain disorders are more likely to affect the senior population, which is propelling the market's development and expansion.

KEY MARKET PLAYERS

Key players in the market are Bristol-Myers Squibb Company, Pfizer, Inc., biOasia Technologies, Inc., Cypress Biosciences, Inc., Janssen Pharmaceutical N.V., Teva Pharmaceuticals Industries, Ltd., F. Hoffmann La-Roche, Ltd., Eli Lilly and Company, Fabre-Kramer Pharmaceuticals, Inc., NeuroVive Pharmaceutical AB, and ArmaGen.,

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods   

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Geography                 

                                5.1.1 Introduction           

                                5.1.2 Europe      

                                                5.1.2.1 UK

                                                5.1.2.2 Spain

                                                5.1.2.3 Germany

                                                5.1.2.4 France

                                                5.1.2.5 Others

                                5.1.3  Y-o-Y Growth Analysis, By Geography        

                                5.1.4  Market Attractiveness Analysis, By Geography      

                                5.1.5  Market Share Analysis, By Geography       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Allon Therapeutics, Inc.                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 AngioChem Inc.                        

                8.3 Genzyme                    

                8.4 CeNeRx BioPharma, Inc                        

                8.5 Bioasis Technologies Inc.                      

                8.6 Ablynx NV                   

                8.7 Capsulution Pharma AG                        

                8.8 International Brain Barriers Society (IBBS)                     

                8.9 Cephalon Inc                              

                8.10 Cognition Pharmaceuticals LLC                         

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Europe Blood Brain Barrier Technologies Market, By Geography, From 2022 to 2027 (USD Million)
  2. Europe BBB Technologies Market, By Region, From 2022 to 2027 (USD Million)
  3. Europe BBB Technologies Market, By Region, From 2022 to 2027 (USD Million)
  4. Europe BBB Technologies Market, By Region, From 2022 to 2027 (USD Million)
  5. Europe BBB Technologies Market, By Region, From 2022 to 2027 (USD Million)
  6. Europe BBB Technologies Market, By Region, From 2022 to 2027 (USD Million)
  7. U.K. Blood Brain Barrier Technologies Market, By Geography, From 2022 to 2027 (USD Million)
  8. Germany Blood Brain Barrier Technologies Market, By Geography, From 2022 to 2027 (USD Million)
  9. France Blood Brain Barrier Technologies Market, By Geography, From 2022 to 2027 (USD Million)
  10. Italy Blood Brain Barrier Technologies Market, By Geography, From 2022 to 2027 (USD Million)
  11. Spain Blood Brain Barrier Technologies Market, By Geography, From 2022 to 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample